31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
New funding supports cutting-edge research into immune cell metabolism
13 October 2025
Read more
Study explores wearable devices to improve blood cancer patient monitoring
8 October 2025
Read more
Blood, sweat and cells: The making of New Zealand’s first CAR T-cell trial
24 September 2025
Read more
Funding boost to improve lung cancer treatment outcomes in Aotearoa New Zealand
5 September 2025
Read more
Cancer, measles and allergic disease research funded in latest HRC grants round
19 August 2025
Read more
Malaghan cancer research double finalists in KiwiNet Research Commercialisation awards
7 August 2025
Read more